EXCESSIVE DAYTIME SLEEPINESS
Clinical trials for EXCESSIVE DAYTIME SLEEPINESS explained in plain language.
Never miss a new study
Get alerted when new EXCESSIVE DAYTIME SLEEPINESS trials appear
Sign up with your email to follow new studies for EXCESSIVE DAYTIME SLEEPINESS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Sleep disorder drug gets extended safety check
Disease control CompletedThis study followed adults with idiopathic hypersomnia, a rare disorder causing extreme daytime sleepiness, to see how safe and effective the medication pitolisant is over the long term. All 119 participants had already completed a previous pitolisant study and continued taking t…
Matched conditions: EXCESSIVE DAYTIME SLEEPINESS
Phase: PHASE3 • Sponsor: Harmony Biosciences Management, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New drug shows promise for long-term control of sudden muscle weakness and sleepiness in narcolepsy
Disease control CompletedThis study tested whether the drug AXS-12 could safely control two main narcolepsy symptoms—cataplexy (sudden muscle weakness) and excessive daytime sleepiness—over a longer period. It involved 68 people with narcolepsy who had already taken part in a previous trial. For 24 weeks…
Matched conditions: EXCESSIVE DAYTIME SLEEPINESS
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Can a wakefulness pill clear brain fog for sleep apnea patients?
Symptom relief CompletedThis study tested whether a medication called solriamfetol could improve mental sharpness in adults with obstructive sleep apnea. The 59 participants had both excessive daytime sleepiness and problems with cognitive function. Over 5 weeks, researchers compared the effects of the …
Matched conditions: EXCESSIVE DAYTIME SLEEPINESS
Phase: PHASE4 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC